Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Nature Medicine
|
July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results
Raffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.
The Journal of Molecular Diagnostics : JMD
|
October 5, 2015
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
Weixin Wang, Meghan Corrigan-Cummins, Emily A Barber, et al.
Molecular Cancer Therapeutics
|
May 2, 2026
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer
Azam Ghafoor, Linying Zhu, Zoe Weaver Ohler, et al.
Cancers
|
July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
Chul Kim, Liqiang Xi, Constance M Cultraro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update
Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 7, 2025
Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease
Xinwei Wu, Frank Villa Hernandez, Haitao Wang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Nature Medicine
|
July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results
Raffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.
The Journal of Molecular Diagnostics : JMD
|
October 5, 2015
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression
Weixin Wang, Meghan Corrigan-Cummins, Emily A Barber, et al.
Molecular Cancer Therapeutics
|
May 2, 2026
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer
Azam Ghafoor, Linying Zhu, Zoe Weaver Ohler, et al.
Cancers
|
July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
Chul Kim, Liqiang Xi, Constance M Cultraro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update
Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 7, 2025
Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease
Xinwei Wu, Frank Villa Hernandez, Haitao Wang, et al.
Page
of 2